AI Verdict
AMGN has stronger fundamentals based on our AI analysis.
AMGN vs MRK Fundamental Comparison
| Metric | AMGN | MRK |
|---|---|---|
| Revenue | $8.6B | $16.3B |
| Net Income | $1.8B | $-4.2B |
| Net Margin | 21.1% | -26.0% |
| ROE | 19.8% | -9.2% |
| ROA | 2.0% | -3.3% |
| Current Ratio | 1.26x | 1.30x |
| Debt/Equity | 6.24x | 1.02x |
| EPS | $3.34 | $-1.72 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
AMGN vs MRK: Frequently Asked Questions
Is AMGN or MRK a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), AMGN has stronger fundamentals. AMGN is rated BUY (79% confidence) while MRK is rated HOLD (78% confidence). This is not investment advice.
How does AMGN compare to MRK fundamentally?
AMGEN INC has ROE of 19.8% vs Merck & Co., Inc.'s -9.2%. Net margins are 21.1% vs -26.0% respectively.
Which stock pays higher dividends, AMGN or MRK?
AMGN has a dividend yield of N/A or no dividend while MRK has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in AMGN or MRK for long term?
For long-term investing, consider that AMGN has BUY rating with 79% confidence, while MRK has HOLD rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about AMGN vs MRK?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For AMGN vs MRK, the AI consensus favors AMGN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.